Samaya S Badrieh, Lisa Bastarache, Xinnan Niu, Jing He, Jamie R Robinson
{"title":"通过遗传学推动儿科 VTE 风险分级的精确性。","authors":"Samaya S Badrieh, Lisa Bastarache, Xinnan Niu, Jing He, Jamie R Robinson","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>This study addresses rising incidence of pediatric venous thromboembolism by validating a VTE phenotype and developing a polygenic risk score (PRS) using UK Biobank data. Our findings demonstrate predictive value of the PRS, enhancing VTE risk assessment in clinical settings. Future steps involve integrating the PRS into risk stratification models.</p>","PeriodicalId":72181,"journal":{"name":"AMIA Joint Summits on Translational Science proceedings. AMIA Joint Summits on Translational Science","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2024-05-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11141856/pdf/","citationCount":"0","resultStr":"{\"title\":\"Driving Precision of Pediatric VTE Risk-stratification through Genetics.\",\"authors\":\"Samaya S Badrieh, Lisa Bastarache, Xinnan Niu, Jing He, Jamie R Robinson\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>This study addresses rising incidence of pediatric venous thromboembolism by validating a VTE phenotype and developing a polygenic risk score (PRS) using UK Biobank data. Our findings demonstrate predictive value of the PRS, enhancing VTE risk assessment in clinical settings. Future steps involve integrating the PRS into risk stratification models.</p>\",\"PeriodicalId\":72181,\"journal\":{\"name\":\"AMIA Joint Summits on Translational Science proceedings. AMIA Joint Summits on Translational Science\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-05-31\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11141856/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"AMIA Joint Summits on Translational Science proceedings. AMIA Joint Summits on Translational Science\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"AMIA Joint Summits on Translational Science proceedings. AMIA Joint Summits on Translational Science","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
Driving Precision of Pediatric VTE Risk-stratification through Genetics.
This study addresses rising incidence of pediatric venous thromboembolism by validating a VTE phenotype and developing a polygenic risk score (PRS) using UK Biobank data. Our findings demonstrate predictive value of the PRS, enhancing VTE risk assessment in clinical settings. Future steps involve integrating the PRS into risk stratification models.